It's funny, but it might not be accurate anymore. Over the last two years, we analyzed 1,227 early-stage biotech startups, and we came across something interesting: Biotech is no longer limited to ...

Amid tough biotech industry market conditions last year, investors and Big Pharma companies were more likely to make deals with later-stage biotechs. Local industry leaders say that could change ...

People who spend a good portion of their days and weeks exploring any field will almost inevitably feel a deep commitment to it. And so for those of us who have spent long days watching the useful ...